Related Experiment Video
Updated: Jan 19, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Myc-dependent endothelial proliferation is controlled by phosphotyrosine 1212 in VEGF receptor-2
Chiara Testini1, Ross O Smith1, Yi Jin1
1Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Abstract:
Exaggerated signaling by vascular endothelial growth factor (VEGF)-A and its receptor, VEGFR2, in pathologies results in poor vessel function. Still, pharmacological suppression of VEGFA/VEGFR2 may aggravate disease. Delineating VEGFR2 signaling in vivo provides strategies for suppression of specific VEGFR2-induced pathways. Three VEGFR2 tyrosine residues (Y949, Y1212, and Y1173) induce downstream signaling. Here, we show that knock-in of phenylalanine to create VEGFR2 Y1212F in C57Bl/6 and FVB mouse strains leads to loss of growth factor receptor-bound protein 2- and phosphoinositide 3'-kinase (PI3K)p85 signaling. C57Bl/6 Vegfr2Y1212F/Y1212F show reduced embryonic endothelial cell (EC) proliferation and partial lethality. FVB Vegfr2Y1212F/Y1212F show reduced postnatal EC proliferation. Reduced EC proliferation in Vegfr2Y1212F/Y1212F explants is rescued by c-Myc overexpression. We conclude that VEGFR2 Y1212 signaling induces activation of extracellular-signal-regulated kinase (ERK)1/2 and Akt pathways required for c-Myc-dependent gene regulation, endothelial proliferation, and vessel stability.
Insights
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Y1212 signaling is crucial for endothelial cell proliferation and vessel stability. Targeting this specific pathway offers new therapeutic strategies for vascular diseases.
Area of Science:
- Molecular Biology
- Cell Biology
- Vascular Biology
Background:
- Vascular Endothelial Growth Factor (VEGF)-A and its receptor, VEGFR2, signaling are critical for blood vessel formation and function.
- Dysregulated VEGFR2 signaling contributes to various pathologies, but its complete suppression can worsen disease.
- Understanding specific VEGFR2 signaling pathways is essential for developing targeted therapeutic strategies.
Purpose of the Study:
- To investigate the role of the VEGFR2 Y1212 tyrosine residue in downstream signaling pathways.
- To determine the impact of VEGFR2 Y1212 signaling on endothelial cell proliferation and embryonic development in vivo.
- To explore potential rescue mechanisms for impaired VEGFR2 signaling.
Main Methods:
- Generation of knock-in mouse models (VEGFR2 Y1212F) in C57Bl/6 and FVB strains.
- Analysis of downstream signaling pathways, including growth factor receptor-bound protein 2 (Grb2) and phosphoinositide 3'-kinase (PI3K)p85.
- Assessment of embryonic and postnatal endothelial cell (EC) proliferation and survival.
- Rescue experiments involving c-Myc overexpression in EC explants.
Main Results:
- VEGFR2 Y1212F mutation abrogated Grb2 and PI3K signaling.
- C57Bl/6 Vegfr2Y1212F/Y1212F mice exhibited reduced embryonic EC proliferation and partial lethality.
- FVB Vegfr2Y1212F/Y1212F mice displayed reduced postnatal EC proliferation.
- c-Myc overexpression rescued EC proliferation in Vegfr2Y1212F/Y1212F explants.
Conclusions:
- VEGFR2 Y1212 signaling activates extracellular-signal-regulated kinase (ERK)1/2 and Akt pathways.
- These pathways are essential for c-Myc-dependent gene regulation, driving endothelial cell proliferation.
- Targeting VEGFR2 Y1212 signaling offers a precise approach to modulate EC function and vessel stability in disease contexts.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Mechanism of Angiogenesis
Abnormal Proliferation

